Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
Adv Ther
.
2017 Jul;34(7):1772.
doi: 10.1007/s12325-017-0563-2.
Authors
Sandra Adsit
1
,
Enrique Rivas Zaldivar
2
,
Howard Sofen
3
,
Ignacio Dei-Cas
4
,
César Maldonado-García
5
,
Elkin O Peñaranda
6
,
Luís Puig
7
,
Xiangyi Meng
8
,
Todd Fox
9
,
Adriana Guana
8
Affiliations
1
TCR Medical Corporation, San Diego, CA, USA.
[email protected]
.
2
Dermos, Guatemala City, Guatemala.
3
UCLA School of Medicine, Los Angeles, CA, USA.
4
Halitus, Buenos Aires, Argentina.
5
Centro Dermatológico "Dr. Ladislao de la Pascua", Mexico City, Mexico.
6
Riesgo de Fractura S.A., Bogota, Colombia.
7
Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
8
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
9
Novartis Pharma AG, Basel, Switzerland.
PMID:
28589404
PMCID:
PMC5504197
DOI:
10.1007/s12325-017-0563-2
No abstract available
Publication types
Published Erratum